Eric Burak

2021

In 2021, Eric Burak earned a total compensation of $3M as Chief Scientific Officer at Fusion Pharmaceuticals, a 62% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$166,164
Option Awards$2,308,284
Salary$458,549
Other$23,599
Total$2,956,597

Burak received $2.3M in option awards, accounting for 78% of the total pay in 2021.

Burak also received $166.2K in non-equity incentive plan, $458.5K in salary and $23.6K in other compensation.

Rankings

In 2021, Eric Burak's compensation ranked 4,484th out of 12,412 executives tracked by ExecPay. In other words, Burak earned more than 63.9% of executives.

ClassificationRankingPercentile
All
4,484
out of 12,412
64th
Division
Manufacturing
1,844
out of 5,498
67th
Major group
Chemicals And Allied Products
768
out of 2,374
68th
Industry group
Drugs
683
out of 2,095
67th
Industry
Biological Products, Except Diagnostic Substances
172
out of 452
62nd
Source: SEC filing on April 29, 2022.

Burak's colleagues

We found two more compensation records of executives who worked with Eric Burak at Fusion Pharmaceuticals in 2021.

2021

John Valliant

Fusion Pharmaceuticals

Chief Executive Officer

2021

John Crowley

Fusion Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like